Enantiospecific disposition of pranoprofen in beagle dogs and rats

Chirality

Volumn 15, Issue 4, 2003, Pages 312-317

  Imai, Teruko ^a   Nomura, Tadayuki ^a   Aso, Mayumi ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

2 arylpropionic acid; Acyl glucuronidation; Chiral inversion; Plasma concentration; Protein binding

Indexed keywords

GLUCURONIDE; PRANOPROFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BILE; CHIRALITY; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG ELIMINATION; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG PROTEIN BINDING; ENANTIOMER; ENANTIOSELECTIVITY; INTESTINE; ISOMER; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOPYRANS; BIOLOGICAL AVAILABILITY; DOGS; GLUCURONIDES; INJECTIONS, INTRAVENOUS; MALE; PROPIONIC ACIDS; RATS; RATS, WISTAR; SPECIES SPECIFICITY; STEREOISOMERISM;

EID: 0037269960     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/chir.10207     Document Type: Conference Paper

References (18)

1. Jamali F, Mehvar R, Pasutto M. Enantioselective aspects of drug action and disposition: therapeutic pitfalls. J Pharm Sci 1989;78:695-715.
2. Caldwell J, Hutt AJ, Fournel-Gigleux S. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem Pharmacol 1988;37:105-114.
3. Jamali F. Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs. Eur J Drug Metab Pharmacokinet 1988;13:1-9.
4. Nomura T, Imai T, Otagiri M. Stereoselective disposition of pranoprofen, a nonsteroidal antiinflammatory drug, in rabbits. Biol Pharm Bull 1993;16:298-303.
5. Tsuji A, Tamai I. Carrier-mediated intestinal transport of drugs. Pharm Res 1996;13:963-977.
6. Stephens RH, O'Neill CA, Warhurst A, Carlson GL, Rowland M, Warhurst G. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J Pharmacol Exp Ther 2001;296:584-591.
7. Suzuki H, Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci 2000;12:3-12.
8. + symporter in the renal brush border membrane. J Biol Chem 1992;267:9565-9573.
9. Ogihara T, Tamai I, Takanaga H, Sai Y, Tsuji A. Stereoselective and carrier-mediated transport of monocarboxylic acids across Caco-2 cells. Pharm Res 1996;13:1828-1832.
10. Arima N, Kato Y. Species differences in absorption, metabolism and excretion of pranoprofen, a 2-arylpropionic acid derivative, in experimental animals. J Pharmacobiodyn 1990;13:739-744.
11. Nomura T, Sakamoto K, Imai T, Otagiri M. Study of interaction of pranoprofen with human serum albumin: binding properties of enantiomers and metabolite. J Pharmacobiodyn 1992;15:589-596.
12. Kato Y, Arima N, Nishimine H. Studies on anti-inflammatory agents. XXXIII. Isolation and identification of the urinary metabolites of 2-(5H-[1]benzopyrano[2,3-b]-pyridin-7-yl)propionic acid (Y-8004) in mice (author's transl.). Yakugaku Zasshi 1976;96:941-944.
13. Menzel S, Beck WS, Brune K, Geisslinger G. Stereoselectivity of biliary excretion of 2-arylpropionates in rats. Chirality 1993;5:422-427.
14. Hutt AJ, Caldwell J. The metabolic chiral inversion of 2-arylpropionic acids - a novel route with pharmacological consequences. J Pharm Pharmacol 1983;35:693-704.
15. Nakamura Y, Yamaguchi T, Takahashi S, Hashimoto S, Iwatani K, Nakagawa Y. Optical isomerization mechanism of R(-)-hydrotropic acid derivatives. J Pharmacobiodyn 1981;4:S-1.
16. Knadler MP, Hall SD. Stereoselective arylpropionyl-CoA thioester formation in vitro. Chirality 1990;2:67-73.
17. Aas M. Organ and subcellular distribution of fatty acid activating enzymes in the rat. Biochim Biophys Acta 1971;231:32-47.
18. Berry BW, Jamali F. Presystemic and systemic chiral inversion of (-)-(R)-fenoprofen in the rat. J Pharmacol Exp Ther 1991;258:695-701.